GLAXO Share Price Target 2050

CAGR-based price projection for GlaxoSmithKline Pharmaceuticals Limited (GLAXO) targeting 2050, derived from official NSE exchange closing prices.

Bear Case (6.3% CAGR)
Rs 12,009
2050 Target
Base Case (15.8% CAGR)
Rs 92,752
2050 Target
Bull Case (44.2% CAGR)
Rs 18,047,068
2050 Target

Current Market Snapshot

CMP: Rs 2,771.10
52W High: Rs 3,106.40
52W Low: Rs 2,103.20
1Y CAGR: 34.0%
3Y CAGR: 15.8%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 2,946 Rs 3,208 Rs 3,995
2028 Rs 3,131 Rs 3,713 Rs 5,761
2029 Rs 3,329 Rs 4,298 Rs 8,306
2030 Rs 3,538 Rs 4,975 Rs 11,975
2031 Rs 3,761 Rs 5,758 Rs 17,266
2032 Rs 3,998 Rs 6,665 Rs 24,894
2033 Rs 4,250 Rs 7,715 Rs 35,892
2034 Rs 4,518 Rs 8,931 Rs 51,749
2035 Rs 4,803 Rs 10,337 Rs 74,612
2036 Rs 5,105 Rs 11,966 Rs 107,576
2037 Rs 5,427 Rs 13,850 Rs 155,104
2038 Rs 5,769 Rs 16,032 Rs 223,630
2039 Rs 6,132 Rs 18,557 Rs 322,430
2040 Rs 6,519 Rs 21,481 Rs 464,882
2041 Rs 6,929 Rs 24,864 Rs 670,268
2042 Rs 7,366 Rs 28,781 Rs 966,396
2043 Rs 7,830 Rs 33,314 Rs 1,393,354
2044 Rs 8,324 Rs 38,562 Rs 2,008,945
2045 Rs 8,848 Rs 44,636 Rs 2,896,506
2046 Rs 9,405 Rs 51,667 Rs 4,176,196
2047 Rs 9,998 Rs 59,806 Rs 6,021,259
2048 Rs 10,628 Rs 69,226 Rs 8,681,480
2049 Rs 11,298 Rs 80,130 Rs 12,516,999
2050 Rs 12,009 Rs 92,752 Rs 18,047,068

Other GLAXO Price Targets

2025 2026 2027 2028 2030 2035 2040

Frequently Asked Questions

What is the GLAXO share price target for 2050?

Based on historical growth analysis, the GLAXO share price target for 2050 ranges from Rs 12,009 (conservative) to Rs 92,752 (base case) to Rs 18,047,068 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of GLAXO?

The current market price of GLAXO (GlaxoSmithKline Pharmaceuticals Limited) is Rs 2,771.10. The 52-week high is Rs 3,106.40 and 52-week low is Rs 2,103.20.

Is GLAXO a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for GLAXO price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 6.3% CAGR), Base (15.8% CAGR), and Bull (optimistic at 44.2% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.